Nova Patents
EP1905830B8

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

Abstract

This record has no abstract on file.

Term

Term ended

Expired 12 October 2020, 5.9 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

Every citation, both ways

Citations
DocumentRelationOffice
EP0897002ACitesEuropean Patent Office (EPO)
WO9404686ACitesWorld Intellectual Property Organization (WIPO)
WO9844106ACitesWorld Intellectual Property Organization (WIPO)
WO9849188ACitesWorld Intellectual Property Organization (WIPO)
DICKENS M ET AL.: "A cytoplasmic inhibitor of the JNK signal transduction pathway" SCIENCE, vol. 277, no. 5326, 1 August 1997 (1997-08-01), pages 693-696, XP002172257Non-patent–
YASUDA J ET AL.: "The JIP group of mitogen-activated protein kinase scaffold proteins" MOLECULAR AND CELLULAR BIOLOGY, vol. 19, no. 10, October 1999 (1999-10), pages 7245-7254, XP002172259Non-patent–
BONNY C ET AL.: "IB1, a JIP-1-related nucelar protein present in insulin-secreting cells" JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 4, 23 January 1998 (1998-01-23), pages 1843-1846, XP002172258Non-patent–
VIVÈS E ET AL.: "A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus." JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 25, 20 June 1997 (1997-06-20), pages 16010-16017, XP002172260Non-patent–
BONNY C ET AL.: "Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death." DIABETES, vol. 50, no. 1, January 2001 (2001-01), pages 77-82, XP002172261Non-patent–